Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

NCT04377659 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped Based on two large, multicenter, randomized trials showed no benefit to tocilizumab in this setting and study has been closed.

Conditions

Interventions

Sponsor

Memorial Sloan Kettering Cancer Center